Vita 34 AG / Key word(s): Half Year Results 22.07.2015 19:34 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Vita 34 AG increases period result and EBITDA above average - Period result increased threefold as of June 30, 2015 compared to the previous year - Earnings per share rose by 160 percent to EUR 0.13 per share compared to last year - Operating result EDITDA rose by 38 percent to EUR 1.1 million - EBIT margin amounted to almost 10 percent already in the first half year Leipzig, July 22, 2015 - Vita 34 AG (WKN A0BL84) publishes its financial figures for the first six months of fiscal year 2015. Total operating revenue increased by 6 percent to EUR 7.1 million following EUR 6.7 million in the prior year's reference period. Revenues generated by Vita 34 rose by 5 percent to EUR 6.4 million (first half-year 2014: EUR 6.1 million), of which EUR 3.3 million were in Q2 2015 (Q2 2014: EUR 2.9 million). Earnings before interest, taxes, depreciation and amortization (EBITDA) increased above average by 38 percent to EUR 1.1 million in the first six months, following EUR 0.8 million in the prior year's period. Measured on revenues Vita 34 achieved a strong EBITDA margin of 17.4 percent (first half-year 2014: 13.4 percent). The period result improved by 300 percent to EUR 0.4 million following EUR 0.1 million in the 2014 reference period. This corresponds to earnings per share of EUR 0.13 (first half-year 2014: EUR 0.05) which represents a 160 percent increase. Apart from international expansion, Vita 34 is pursuing the goal of further extending the value chain via the development and introduction of new products for pharmaceutical manufacture, thereby achieving significant, new market positions. The complete interim report for the first six months of 2015 is available for download as of July 23, 2015 on the website at www.vita34group.com in the "Investor Relations" section. Additional information: ISIN: DE000A0BL849 WKN: A0BL84 Ticker symbol: V3V Market segment: Regulated Market (Prime Standard) of the Frankfurt Stock Exchange Vita 34 AG Deutscher Platz 5 04103 Leipzig Germany END OF THE AD-HOC NOTICE 22.07.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig Germany Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: [email protected] Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------